Oxecta — Class III drug recall D-0403-2015
Terminated recall by Pfizer Inc., reported 2015-03-11, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0403-2015 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pfizer Inc., New York, NY, United States |
| Recall initiated | 2015-02-26 |
| Classified | 2015-03-05 |
| Reported by FDA | 2015-03-11 |
| Terminated | 2017-07-29 |
| Distributed | Nationwide (US) |
| Quantity | 137 bottles |
| Reason classes | specification failure |
| NDC | 60793-0525-01 |
| Lot numbers | 12/15, 13T02 |
Product
Oxecta(TM) (oxycodone HCl) tablets, 5 mg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc. Bristol, TN, NDC 60793-525-01
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0403-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.